The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

Citation
Aj. Wigg et al., The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis, GUT, 48(2), 2001, pp. 206-211
Citations number
20
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
GUT
ISSN journal
00175749 → ACNP
Volume
48
Issue
2
Year of publication
2001
Pages
206 - 211
Database
ISI
SICI code
0017-5749(200102)48:2<206:TROSIB>2.0.ZU;2-N
Abstract
Background-Small intestinal bacterial overgrowth may contribute to the deve lopment of non-alcoholic steatohepatitis, perhaps by increasing intestinal permeability and promoting the absorption endotoxin or other enteric bacter ial products. Aims-To investigate the prevalence small intestinal bacterial overgrowth, i ncreased intestinal permeability, elevated endotoxin, and tumour necrosis f actor alpha (TNF-alpha) levels in patients with nonalcoholic steatohepatiti s and in control subjects. Patients and methods-Twenty two patients with non-alcoholic steatohepatitis and 23 control subjects were studied. Small intestinal bacterial overgrowt h was assessed by a combined C-14-D-xylose and lactulose breath test. Intes tinal permeability was assessed by a dual lactuloserhamnose sugar test. Ser um endotoxin levels were determined using the limulus amoebocyte lysate ass ay and TNF-alpha levels using an ELISA. Results-Small intestinal bacterial overgrowth was present in 50% of patient s with non-alcoholic steatosis and 22% of control subjects (p=0.048). Mean TNF-alpha levels in non-alcoholic steatohepatitis patients and control subj ects were 14.2 and 7.5 pg/ml, respectively (p=0.001). Intestinal permeabili ty and serum endotoxin levels were similar in the two groups. Conclusions-Patients with non-alcoholic steatohepatitis have a higher preva lence of small intestinal bacterial overgrowth, as assessed by the C-14-D - xylose-lactulose breath test, and higher TNF-alpha levels in comparison wit h control subjects. This is not accompanied by increased intestinal permeab ility or elevated endotoxin levels.